Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DX
3301
Dynex Capital
DX
$3.18B
| $2.51M | ﹤0.01% |
175,546
-7,059
| -4% | -$94.4K |
|
3302
MarineMax
HZO
$776M
| $2.51M | ﹤0.01% |
112,052
-224,963
| -67% | -$3.7M |
|
3303
WisdomTree Dynamic International Equity Fund
DDWM
$1.5B
| $2.5M | ﹤0.01% |
98,817
-9,759
| -9% | -$240K |
|
|
CBIO
3304
Crescent Biopharma
CBIO
$610M
| $2.49M | ﹤0.01% |
6,629
+1,829
| +38% | +$518K |
|
3305
Rigel Pharmaceuticals
RIGL
$733M
| $2.49M | ﹤0.01% |
136,253
-114,905
| -46% | -$2.07M |
|
|
AQUA
3306
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $2.49M | ﹤0.01% |
133,839
+72,882
| +120% | +$1.21M |
|
|
ACP
3307
abrdn Income Credit Strategies Fund
ACP
$635M
| $2.48M | ﹤0.01% |
279,010
-42,922
| -13% | -$342K |
|
3308
MakeMyTrip
MMYT
$5.65B
| $2.48M | ﹤0.01% |
161,774
+22,844
| +16% | +$339K |
|
3309
Griffon
GFF
$4.88B
| $2.48M | ﹤0.01% |
133,809
+8,990
| +7% | +$146K |
|
3310
AZZ Inc
AZZ
$4.53B
| $2.48M | ﹤0.01% |
72,186
-15,898
| -18% | -$486K |
|
|
PHD
3311
DELISTED
Pioneer Floating Rate Fund
PHD
| $2.48M | ﹤0.01% |
260,271
-12,684
| -5% | -$112K |
|
3312
Silicom
SILC
$239M
| $2.47M | ﹤0.01% |
67,427
+31,636
| +88% | +$1.02M |
|
|
AMED
3313
DELISTED
Amedisys
AMED
| $2.47M | ﹤0.01% |
12,455
-28,479
| -70% | -$5.31M |
|
3314
State Street SPDR MSCI USA StrategicFactors ETF
QUS
$1.57B
| $2.47M | ﹤0.01% |
27,983
+3,290
| +13% | +$281K |
|
3315
Howard Hughes
HHH
$4.06B
| $2.47M | ﹤0.01% |
49,814
-84,720
| -63% | -$4.27M |
|
|
PGZ
3316
Principal Real Estate Income Fund
PGZ
$68.5M
| $2.47M | ﹤0.01% |
205,177
+57,632
| +39% | +$697K |
|
3317
Columbia Sportswear
COLM
$2.93B
| $2.46M | ﹤0.01% |
30,582
-111,703
| -79% | -$8.14M |
|
|
MYJ
3318
DELISTED
Blackrock Muni Yield New Jersey Fund, Inc.
MYJ
| $2.46M | ﹤0.01% |
180,969
+4,036
| +2% | +$53.7K |
|
3319
G-III Apparel Group
GIII
$1.51B
| $2.46M | ﹤0.01% |
185,164
-397,674
| -68% | -$4.39M |
|
3320
OneSpan
OSPN
$598M
| $2.46M | ﹤0.01% |
88,061
+3,609
| +4% | +$70.9K |
|
3321
Fulgent Genetics
FLGT
$510M
| $2.46M | ﹤0.01% |
153,611
+104,779
| +215% | +$1.6M |
|
3322
Opko Health
OPK
$985M
| $2.46M | ﹤0.01% |
720,260
-1,387,131
| -66% | -$3.11M |
|
3323
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund
TLTE
$344M
| $2.46M | ﹤0.01% |
54,944
+3,065
| +6% | +$130K |
|
|
EGRX
3324
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.45M | ﹤0.01% |
51,082
+1,773
| +4% | +$88.5K |
|
|
AFB
3325
AllianceBernstein National Municipal Income Fund
AFB
$314M
| $2.45M | ﹤0.01% |
183,364
-59,153
| -24% | -$765K |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,644 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.